Total Payments
$7,899
2024 Payments
$2,978
Companies
28
Transactions
323
Medicare Patients
2,325
Medicare Billing
$123,376
Payment Breakdown by Category
Food & Beverage$7,727 (97.8%)
Education$171.94 (2.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,727 | 320 | 97.8% |
| Education | $171.94 | 3 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,449 | 67 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $768.65 | 33 | $0 (2024) |
| Janssen Biotech, Inc. | $759.97 | 39 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $615.40 | 31 | $0 (2024) |
| Incyte Corporation | $569.59 | 16 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $541.62 | 19 | $0 (2024) |
| GENZYME CORPORATION | $463.78 | 24 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $388.53 | 16 | $0 (2024) |
| LEO Pharma Inc. | $311.94 | 3 | $0 (2024) |
| Amgen Inc. | $303.68 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,978 | 129 | ABBVIE INC. ($613.40) |
| 2023 | $2,500 | 109 | Janssen Biotech, Inc. ($427.80) |
| 2022 | $2,420 | 85 | ABBVIE INC. ($436.57) |
All Payment Transactions
323 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $10.02 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: Inflammation | ||||||
| 12/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $5.06 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Galderma Laboratories, L.P. | AKLIEF (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: ACNE | ||||||
| 12/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $25.23 | General |
| Category: Immunology | ||||||
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $6.62 | General |
| Category: Immunology | ||||||
| 11/27/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $8.89 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/19/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $28.50 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $21.16 | General |
| Category: Dermatology | ||||||
| 11/18/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: Dermatology | ||||||
| 11/14/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: Immunology | ||||||
| 11/06/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $11.86 | General |
| Category: Immunology | ||||||
| 11/06/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $6.67 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: DERMATOLOGY | ||||||
| 10/28/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: Immunology | ||||||
| 10/24/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $30.94 | General |
| Category: Immunology | ||||||
| 10/23/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: Immunology | ||||||
| 10/23/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: IMMUNOLOGY | ||||||
| 10/23/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Odomzo (Drug), BLU-U | Food and Beverage | In-kind items and services | $16.63 | General |
| Category: Oncology | ||||||
| 10/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $6.37 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $26.72 | General |
| Category: Immunology | ||||||
| 10/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: IMMUNOLOGY | ||||||
| 10/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: Immunology | ||||||
| 10/14/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.59 | General |
| Category: Immunology | ||||||
| 10/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $6.01 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,596 | 3,011 | $328,206 | $83,598 |
| 2022 | 11 | 729 | 1,292 | $138,843 | $39,778 |
Total Patients
2,325
Total Services
4,303
Medicare Billing
$123,376
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 305 | 400 | $72,800 | $19,786 | 27.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 211 | 253 | $52,371 | $12,119 | 23.1% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 149 | 191 | $43,166 | $11,426 | 26.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 235 | 307 | $38,989 | $7,673 | 19.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 96 | 96 | $21,408 | $5,211 | 24.3% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 91 | 165 | $17,325 | $4,861 | 28.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 131 | 155 | $17,515 | $4,663 | 26.6% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 40 | 50 | $16,400 | $4,582 | 27.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 193 | 1,180 | $15,340 | $4,542 | 29.6% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 34 | 42 | $14,826 | $4,194 | 28.3% |
| 11104 | Punch biopsy, first skin growth | Office | 2023 | 22 | 23 | $5,934 | $1,626 | 27.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 20 | 22 | $5,720 | $1,518 | 26.5% |
| 69100 | Biopsy of ear | Office | 2023 | 14 | 15 | $2,940 | $596.40 | 20.3% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 14 | 14 | $2,030 | $494.45 | 24.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 23 | 30 | $1,170 | $246.40 | 21.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 18 | 68 | $272.00 | $58.10 | 21.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 130 | 158 | $28,756 | $8,757 | 30.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 101 | 110 | $22,770 | $6,144 | 27.0% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 73 | 83 | $18,758 | $5,594 | 29.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 121 | 145 | $18,415 | $4,078 | 22.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 80 | 91 | $10,283 | $3,159 | 30.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 20 | 26 | $8,528 | $2,735 | 32.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 41 | 41 | $9,143 | $2,633 | 28.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 90 | 542 | $7,046 | $2,233 | 31.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 41 | 63 | $6,615 | $2,010 | 30.4% |
About Jessica Adams
Jessica Adams is a Family healthcare provider based in Spring Hill, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/18/2022. The National Provider Identifier (NPI) number assigned to this provider is 1174278030.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jessica Adams has received a total of $7,899 in payments from pharmaceutical and medical device companies, with $2,978 received in 2024. These payments were reported across 323 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($7,727).
As a Medicare-enrolled provider, Adams has provided services to 2,325 Medicare beneficiaries, totaling 4,303 services with total Medicare billing of $123,376. Data is available for 2 years (2022–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Spring Hill, TN
- Active Since 02/18/2022
- Last Updated 02/18/2022
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1174278030
Products in Payments
- DUPIXENT (Biological) $1,203
- TREMFYA (Drug) $864.22
- RINVOQ (Biological) $718.44
- SKYRIZI (Biological) $647.62
- OPZELURA (Drug) $569.59
- Sotyktu (Drug) $388.53
- COSENTYX (Drug) $344.11
- ADBRY (Biological) $311.94
- TALTZ (Drug) $290.89
- Otezla (Drug) $284.09
- Zoryve (Drug) $208.36
- AKLIEF (Drug) $187.44
- ILUMYA (Biological) $173.78
- Winlevi (Drug) $162.30
- Bimzelx (Biological) $128.29
- PURAPLY (Medical Supply) $113.12
- Odomzo (Drug) $110.55
- LIBTAYO (Biological) $99.24
- Cabtreo (Drug) $91.98
- Cimzia (Drug) $81.73
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Spring Hill
Brenda Sanchez, Np, NP
Family — Payments: $10,684
Family $10,684
Ms. Ann-Marie Davidson, Aprn, APRN
Family — Payments: $5,683
Family $5,683
Ms. Samia Boufares, Aprn, APRN
Family — Payments: $4,743
Family $4,743
Kelly Odum, Fnp-C, FNP-C
Family — Payments: $4,058
Family $4,058
Laura Murff, Fnp, FNP
Family — Payments: $3,881
Family $3,881
Jennifer Conran, Aprn, APRN
Family — Payments: $3,554
Family $3,554